The 20 Best Acute Erythroid Leukemia (AEL) Doctors in The United States

. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

To provide state of the art medical care for our patients in a friendly, and compassionate setting. Dr. Shirinian is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 70 other conditions, according to our data. His clinical expertise encompasses Acute Erythroid Leukemia (AEL), Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Shirinian is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Shirinian is currently accepting new patients.

Shamila Garg is a Hematologist and an Oncologist practicing medicine in Evergreen Park, Illinois. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Prostate Cancer. Dr. Garg is board certified in American Board Of Internal Medicine.

Malgorzata Mcmasters is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Mcmasters is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myelomonocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Mcmasters is board certified in American Board Of Internal Medicine.

David Avigan is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Avigan is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Avigan is board certified in American Board Of Internal Medicine.

Ajay Tadepalli is an Oncologist practicing medicine in Johns Creek, Georgia. He has been practicing medicine for over 21 years. Dr. Tadepalli is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Tadepalli is board certified in American Board Of Internal Medicine, 2014.

Dr. Alexander J. Ambinder is an instructor of medicine at the Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins. Dr. Ambinder has expertise in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and bone marrow transplantation. Dr. Ambinder received his B.A. from Washington University in St. Louis. He earned his M.D. from Emory University School of Medicine and his M.P.H. from Emory University Rollins School of Public Health. He completed the Osler Medical Residency Training Program in internal medicine at Johns Hopkins and subsequently served as an Assistant Chief of Service (Chief Resident). He completed his fellowships in Hematology and Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and also served as a Chief Fellow. Dr. Ambinder is a member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Ambinder’s principle research interest is in designing and conducting clinical trials inspired by laboratory insights to improve the management of acute myeloid leukemia and myelodysplastic syndrome. He also has an interest in building large databases that will yield insights that allow for more personalized approaches to the care and treatment of patients with blood cancers. Dr. Ambinder is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Joseph Rimando is a Hematologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 10 years. Dr. Rimando is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Acute Erythroid Leukemia (AEL), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant. Dr. Rimando is board certified in American Board Of Internal Medicine, 2019.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dezern is board certified in American Board Of Internal Medicine.

Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gojo is board certified in American Board Of Internal Medicine.

Benjamin Ebert is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Ebert is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Pure Red Cell Aplasia, Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine.

Jaroslaw Maciejewski is a Hematologist practicing medicine in Cleveland, Ohio. Dr. Maciejewski is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Splenectomy.

Swaleh Bahamadi is a Hematologist and an Oncologist practicing medicine in Leland, North Carolina. He has been practicing medicine for over 24 years. Dr. Bahamadi is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Myeloproliferative Neoplasms (MPN), Familial Pancreatic Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Bahamadi is board certified in Hematology.

David Grinblatt, MD, a hematologist at Endeavor Health Cancer Institute, specializes in diagnosing and treating blood disorders using the most advanced and effective therapies available. He is actively involved in bringing CAR-T cell therapy to patients, reflecting his commitment to innovation and personalized care. Dr. Grinblatt values optimism and clear communication and works closely with patients to develop treatment plans that align with their unique situation and diagnosis. Dr. Grinblatt is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Grinblatt is board certified in American Board Of Internal Medicine.

Dr. Hu is a 2017-2021 Seattle Met Magazine Top Doctor Award winner. Her cancer research experience has helped her follow advances in oncology and apply up-to-date treatment to her patients. Dr. Hu believes each individual is unique, and is dedicated to providing personalized, patient-centered care. Her goal is to be a patient’s advocate; helping them to understand their medical conditions while providing the best available treatment to suit their needs. Dr. Hu is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Acute Erythroid Leukemia (AEL), and Thrombocytopenia. Dr. Hu is board certified in American Board Of Internal Medicine. Dr. Hu is currently accepting new patients.

Shailaja Hegde is a primary care provider, practicing in Internal Medicine in Fort Myers, Florida. Dr. Hegde is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Erythroid Leukemia (AEL), Menopause, Familial Combined Hyperlipidemia, and Xanthoma.

Mark Litzow is a Hematologist practicing medicine in Rochester, Minnesota. Dr. Litzow is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Graft.

Hassan Alkhateeb is a Hematologist practicing medicine in Rochester, Minnesota. He has been practicing medicine for over 18 years. Dr. Alkhateeb is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Alan List is a Hematologist practicing medicine in Tampa, Florida. Dr. List is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.